KA
Krishna Abhiram Cherukuri
About Krishna Abhiram Cherukuri
Data last updated:
Krishna Abhiram Cherukuri is a Director at Biochemical And Synthetic Products Private Limited (since 2020), Director at Basis Laboratories Private Limited (since 2024) and Designated Partner at Phanes Biomax Llp (since 2017). The companies operate in Pharma and Chemicals and Materials. The 2 current companies with reported revenue have a combined latest revenue of ₹84.39 Cr; the largest is Biochemical And Synthetic Products Private Limited at ₹74.99 Cr (FY 2025). Earlier, Krishna Abhiram Cherukuri was an Additional Director at Chemoleums India Private Limited (2014–2017) and Additional Director at City Lubricants Private Limited (2015–2017).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Biochemical And Synthetic Products Private Limited U24110TG1943PTC000621 | Director | 04 Sep 2020 | 1943 | ₹74.99 Cr (FY 2025) | Active |
 Basis Laboratories Private Limited U24302TG2016PTC112890 | Director | 21 Sep 2024 | 2016 | ₹9.40 Cr (FY 2023) | Active |
 Phanes Biomax Llp AAI-6621 | Designated Partner | 24 Feb 2017 | 2017 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Chemoleums India Private Limited U11100TN2009PTC070694 | Additional Director | 10 Sep 2014 | 2009 | ₹116 Cr (FY 2019) | Amalgamated |
| City Lubricants Private Limited U23209TN1991PTC091803 | Additional Director | 19 Oct 2015 | 1991 | ₹80.83 Cr (FY 2023) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Krishna Abhiram Cherukuri
| Name | DIN | Company | Designation |
|---|---|---|---|
| Cherukuri Sumithra | 02111331 | Biochemical And Synthetic Products Private Limited , Basis Laboratories Private Limited | Director |
| Surekha Cherukuri | 08741198 | Biochemical And Synthetic Products Private Limited , Basis Laboratories Private Limited | Director |
| Narsing Rao Singayapally | 00800362 | Basis Laboratories Private Limited | Director |
| Nikhil Khandelwal | Basis Laboratories Private Limited | Company Secretary | |
| Singayapally Vinatha | 07627752 | Basis Laboratories Private Limited | Director |
| Srinivas Rao Nimmala | 07810652 | Basis Laboratories Private Limited | Managing Director |
| Chilakapati Praveen | 00497851 | Phanes Biomax Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Krishna Abhiram Cherukuri
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Krishna Abhiram Cherukuri
Krishna Abhiram Cherukuri currently holds 3 directorships: Biochemical And Synthetic Products Private Limited (Director, since 04 Sep 2020, revenue ₹74.99 Cr (FY 2025)); Basis Laboratories Private Limited (Director, since 21 Sep 2024, revenue ₹9.40 Cr (FY 2023)); Phanes Biomax Llp (Designated Partner, since 24 Feb 2017).
Krishna Abhiram Cherukuri was first appointed on 10 Sep 2014 as Additional Director at Chemoleums India Private Limited. The most recent appointment on record is 21 Sep 2024 at Basis Laboratories Private Limited.
The 2 current companies of Krishna Abhiram Cherukuri that report revenue have a combined latest revenue of ₹84.39 Cr: Biochemical And Synthetic Products Private Limited ₹74.99 Cr (FY 2025); Basis Laboratories Private Limited ₹9.40 Cr (FY 2023).
Krishna Abhiram Cherukuri held 2 earlier board appointments: Chemoleums India Private Limited (Additional Director, 10 Sep 2014 to 06 Dec 2017); City Lubricants Private Limited (Additional Director, 19 Oct 2015 to 12 Dec 2017).
The current boards of Krishna Abhiram Cherukuri's companies include Cherukuri Sumithra (Biochemical And Synthetic Products Private Limited), Surekha Cherukuri (Biochemical And Synthetic Products Private Limited), Narsing Rao Singayapally (Basis Laboratories Private Limited), Nikhil Khandelwal (Basis Laboratories Private Limited), Singayapally Vinatha (Basis Laboratories Private Limited), Srinivas Rao Nimmala (Basis Laboratories Private Limited), among others.